Adaptive Biotechnologies: Q4 Earnings Insights

Adaptive Biotechnologies ADPT reported its Q4 earnings results on Wednesday, February 14, 2024 at 04:05 PM.

Here's what investors need to know about the announcement.

Earnings

Adaptive Biotechnologies reported in-line EPS of $-0.3 versus an estimate of $-0.3.

Revenue was down $9.41 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.01 which was followed by a 18.18% drop in the share price the next day.

Here's a look at Adaptive Biotechnologies's past performance:

Quarter Q3 2023 Q2 2023 Q1 2023 Q4 2022
EPS Estimate -0.34 -0.33 -0.38 -0.35
EPS Actual -0.35 -0.33 -0.40 -0.28
Revenue Estimate 42.96M 45.48M 36.81M 55.27M
Revenue Actual 37.92M 48.93M 37.65M 55.20M

To track all earnings releases for Adaptive Biotechnologies visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Date
▲▼
ticker
▲▼
name
▲▼
Actual EPS
▲▼
EPS Surprise
▲▼
Actual Rev
▲▼
Rev Surprise
▲▼
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!